CERUS CORP (CERS)
Surgical & Medical Instruments & Apparatus
Latest Price
$2.49
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.35
P/B Ratio
7.02
Valuation metrics
adjust assumptions →Base FCF: $5M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$0.21
92% downside
Institutional Ownership
72.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 22.22M | $64.0M | 11.26% | +639.7K | 2026-06-30 |
| ARK Investment Management LLC | 17.93M | $52.0M | 9.09% | -1.23M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.56M | $25.0M | 4.34% | +431.6K | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 6.40M | $18.0M | 3.24% | -3.61M | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 5.49M | $16.0M | 2.78% | +1.75M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 5.12M | $14.0M | 2.59% | +481.6K | 2026-06-30 |
| STATE STREET CORP | 4.75M | $13.0M | 2.41% | +539.1K | 2026-06-30 |
| Senvest Management, LLC | 4.61M | $13.0M | 2.34% | +500.0K | 2026-06-30 |
| Sumitomo Mitsui Trust Group, Inc. | 4.14M | $12.0M | 2.10% | -377.1K | 2026-06-30 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 4.08M | $11.0M | 2.07% | -164.2K | 2026-06-30 |